|Title:||Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis|
|Abstract:||Somatostatin peptides bearing at least one chelating group for a detectable element, said chelating group being linked to an amino group of said peptide, and said amino group having no significant binding affinity for somatostatin receptors, in free or salt form, are complexed with a detectable element and are useful as a pharmaceutical, e.g. a radiopharmaceutical for in vivo imaging of somatostatin receptor positive tumors or for therapy.|
|Inventor(s):||Albert; Rainer (Basel, CH), Krenning; Eric P. (Capelle, NL), Lamberts; Steven W. J. (Rotterdam, NL), Pless; Janos (Basel, CH)|
|Assignee:||Novartis AG (Basel, CH)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.